IRIS
DI BENEDETTO, Antonino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.205
NA - Nord America 8.729
AS - Asia 4.977
SA - Sud America 1.692
AF - Africa 177
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 6
Totale 26.795
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.564
RU - Federazione Russa 5.044
SG - Singapore 2.171
CN - Cina 1.469
BR - Brasile 1.452
IT - Italia 1.239
IE - Irlanda 1.218
SE - Svezia 1.085
DE - Germania 630
FR - Francia 579
HK - Hong Kong 489
UA - Ucraina 467
FI - Finlandia 261
GB - Regno Unito 254
VN - Vietnam 236
PL - Polonia 169
IN - India 124
BD - Bangladesh 82
AR - Argentina 76
CA - Canada 63
TR - Turchia 58
IQ - Iraq 57
MX - Messico 54
NL - Olanda 53
EC - Ecuador 50
BE - Belgio 46
ZA - Sudafrica 43
EG - Egitto 39
JP - Giappone 35
ES - Italia 33
AT - Austria 29
MA - Marocco 28
PK - Pakistan 26
CO - Colombia 25
ID - Indonesia 25
CZ - Repubblica Ceca 23
UZ - Uzbekistan 23
SA - Arabia Saudita 22
IR - Iran 18
VE - Venezuela 18
AZ - Azerbaigian 17
UY - Uruguay 17
DZ - Algeria 16
TN - Tunisia 14
CL - Cile 13
IL - Israele 13
JM - Giamaica 13
PE - Perù 13
PY - Paraguay 13
JO - Giordania 12
KE - Kenya 11
LT - Lituania 11
PH - Filippine 11
CH - Svizzera 10
AE - Emirati Arabi Uniti 9
BO - Bolivia 9
KG - Kirghizistan 9
LB - Libano 9
NP - Nepal 9
CI - Costa d'Avorio 8
RO - Romania 8
BG - Bulgaria 7
KZ - Kazakistan 7
MY - Malesia 7
SN - Senegal 7
GE - Georgia 6
GR - Grecia 6
KR - Corea 6
PA - Panama 6
SY - Repubblica araba siriana 6
EU - Europa 5
GT - Guatemala 5
GY - Guiana 5
LV - Lettonia 5
NI - Nicaragua 5
AL - Albania 4
AU - Australia 4
DO - Repubblica Dominicana 4
EE - Estonia 4
HN - Honduras 4
HU - Ungheria 4
MD - Moldavia 4
PS - Palestinian Territory 4
RS - Serbia 4
BB - Barbados 3
BH - Bahrain 3
NG - Nigeria 3
OM - Oman 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BW - Botswana 2
BY - Bielorussia 2
CR - Costa Rica 2
LU - Lussemburgo 2
MN - Mongolia 2
MU - Mauritius 2
QA - Qatar 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
Totale 26.776
Salva come PNG Salva come JPEG
Città #
Moscow 1.445
Ashburn 1.324
Singapore 1.222
Dublin 1.218
Chandler 970
Jacksonville 893
Dallas 823
Nyköping 545
Beijing 536
Hong Kong 486
San Jose 390
The Dalles 219
Princeton 212
Boardman 199
Cambridge 195
Los Angeles 194
Lauterbourg 190
Dearborn 175
Messina 170
Des Moines 162
Medford 155
Warsaw 154
Ann Arbor 147
Munich 126
São Paulo 121
Buffalo 98
New York 87
Bremen 72
Council Bluffs 69
Ho Chi Minh City 69
Jinan 67
Tianjin 66
Milan 65
Wilmington 63
Santa Clara 58
Shenyang 57
Florence 55
Woodbridge 55
Redondo Beach 54
Frankfurt am Main 53
Rome 53
Turku 50
Guangzhou 46
Brussels 45
Hanoi 44
Lancaster 44
Orem 44
San Mateo 40
Belo Horizonte 38
Catania 36
Rio de Janeiro 34
Düsseldorf 33
Cairo 32
Tokyo 30
Nanjing 29
Naples 28
Seattle 28
Brooklyn 27
Chennai 27
Pune 27
Curitiba 26
Zhengzhou 26
Haikou 25
Chicago 24
Hebei 24
Houston 24
Montreal 24
Brasília 23
Johannesburg 23
London 23
Quito 23
Shanghai 23
Baghdad 21
Porto Alegre 20
Salvador 20
San Francisco 20
Tashkent 20
Ningbo 19
Denver 18
Hangzhou 18
Helsinki 18
Shenzhen 18
Stockholm 18
Atlanta 17
Guayaquil 17
Manchester 16
Mexico City 16
Nuremberg 16
Olomouc 16
Phoenix 16
Vienna 16
Washington 16
Bologna 15
Boston 15
Guarulhos 15
Hyderabad 15
Montevideo 15
Baku 14
Goiânia 14
Recife 14
Totale 14.755
Salva come PNG Salva come JPEG
Nome #
VALUTAZIONE DEI LIVELLI DI LIPOPROTEINA(A) ED INSULINA DURANTE E DOPO LA GRAVIDANZA. DATI PRELIMINARI 890
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial 248
"Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL. 235
1ST-PHASE INSULIN-RESPONSE TO INTRAVENOUS GLUCOSE IN CYSTIC- FIBROSIS PATIENTS WITH DIFFERENT DEGREES OF GLUCOSE-TOLERANCE 234
Altered platelet magnesium and plasma and urinary soluble form of intercellular adhesion molecule I (sICAM-1) concentrations in insulin dependent diabetes mellitus (IDDM) patients with microalbuminuria. 230
Adiponectin and insulin resistance in early- and late-onset pre-eclampsia 229
Depressione, ansia e rabbia in soggetti affetti da diabete mellito di tipo 1 [Depression, anxiety and anger in patients with type 1 diabetes mellitus] 221
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria 220
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial 219
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 217
Personality, Alexithymia, and Anger in a sample of adults affected by Type 1 Juvenile-Onset Diabetes. 210
Italian risk factor-based screening for gestational diabetes. 208
Association between maternal serum high mobility group box 1 levels and pregnancy complicated by gestational diabetes mellitus 208
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 206
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy 205
Different concentration of human cord blood HMGB1 according to delivery and labour: A pilot study 205
A single abnormal value of the glucose tolerance test is related to increased adverse perinatal outcome. 204
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 202
A GENETIC-POLYMORPHISM OF THE APOLIPOPROTEIN AI-CIII GENE- CLUSTER IS ASSOCIATED WITH CORONARY HEART-DISEASE IN NON- INSULIN-DEPENDENT DIABETES-MELLITUS 201
Erectile dysfunction in compensated liver cirrhosis 199
Age and metabolic control influence lens opacity in type I, insulin-dependent diabetic patients 195
High Prevalence of Arcobacter Carriage in Older Subjects with Type 2 Diabetes 195
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 194
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 192
Myo-inositol may prevent gestational diabetes in PCOS women 191
EFFETTO DEL POLIMORFISMO CETP TAQ1B SUL PROFILO LIPIDICO E SULLE SOTTOPOLAZIONI HDL NELLE DONNE CON E SENZA DIABETE DI TIPO 2 183
Effects of myo-inositol on glucose variability in women with gestational diabetes 183
Anticorpi anti P-53 in pazienti con diabete mellito di tipo 1 181
Epidemiology of intensive care unit-acquired sepsis in Italy: Results of the SPIN-UTI network 181
Cardiac diastolic evaluation in pregnant women with abnormal glucose tolerance: an opportunity to detect the early and subclinical alterations and prevent cardiovascular diseases 180
C-reactive protein as an early predictor of gestational diabetes mellitus 179
SCLEROSTIN LEVELS IN TYPE 1 DIABETES MELLITUS: GENEDER DIFFERENCES AND ASSOCIATION WITH CLINICAL FEATURES 173
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome 170
First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes 169
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 169
APOLIPOPROTEIN A1 GENE PROMOTER POLYMORPHISM AND CORONARY HEART-DISEASE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS 168
Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis 168
Carotid atherosclerosis and lipid profile in a diabetic population: a retrospective evaluation 165
The complex interplay between clinical and person-centered diabetes outcomes in the two genders 165
Nuove evidenze sul ruolo della supplementazione con inositolo nel diabete gestazionale 164
Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. 163
Anti-p53 autoantibodies in patients with IDDM 162
Epatite C: un fattore di rischio per il diabete? 162
Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance 162
Improvement of selective screening strategy for gestational diabetes through a more accuratedefinition of high-risk groups 162
Hypoplastic nails and brachydactyly in a girl with moderate acne and hirsutism 161
Age and metabolic control influence lens opacity in IDDM patients 160
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 158
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes–a randomized and open-label, placebo-controlled clinical trial 158
Correlates of total homocysteine plasma concentration in type 2 diabetes 157
SCLEROSTIN AND DICKKOPF-1 LEVELS IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 157
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 156
Myo-inositol supplementation and the onset of gestational diabetes mellitus in pregnant women with a family hystory of type 2 diabetes. A prospective, randomized, placebo controlled study 155
High mobility group protein B1: a new biomarker of obesity in pregnant women? 155
Serum thyroid hormone autoantibodies in type 1 diabetes mellitus 154
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 153
CORRESPONDENCE BETWEEN FIRST TRIMESTER FASTING GLICEMIA AND ORAL GLUCOSE TOLERANCE TEST IN GESTATIONAL DIABETES DIAGNOSIS 152
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 149
Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders 148
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 148
GENDER DIFFERENCES IN THE RELATIONSHIP BETWEEN METABOLIC SYNDROME AND ANGER EXPRESSION. 148
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 147
Epatite C: un fattore di rischio per il diabete? 146
A multicenter Italian study on pregnancy outcome in women with diabetes 145
C-reactive protein as an early predictor of gestational diabetes mellitus. 144
Alterazioni della funzione urodinamica nel diabete mellito di tipo 2 143
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica 143
Is diabetes mellitus a risk factor for HCV infection? 142
CAROTID ATHEROSCLEROSIS AND LIPID PROFILE IN A DIABETIC POPULATION: A RETROSPECTIVE EVALUATION 142
Studio eco-strain degli effetti del trattamento con Genisteina sul ventricolo sinistro in donne in post-menopausa con sindome metabolica (Strain-Echo Assessment of Left Ventricular Effects of Genistein Treatment in Post-Menopausal Women with Metabolic Syndrome). 142
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 141
Relationship between serum erythropoietin levels and rT3, T4 concentrations in elderly patients with non-thyroidal illnesses 140
Midtrimester Amniotic Fluid Leptin and Insulin Levels and Subsequent Gestational Diabetes. 139
Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women. 139
Myoinositol plus α‑lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study 138
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 137
Algorithms for personalized therapy of type 2 diabetes: results of a web-based international survey 137
APOLIPOPROTEIN-B AND APOLIPOPROTEIN-A-I/C-III GENETIC POLYMORPHISMS AND CORONARY HEART-DISEASE IN DIABETES-MELLITUS 136
A computerized network of diabetes clinics as a tool for quality of care improvement: the experience of Club Diabete Sicili@ 136
La disfunzione diastolica nel diabete gestazionale 136
DIFFERENT DAILY BLOOD GLUCOSE CONTROL AND FREE INSULIN LEVELS DURING TREATMENT WITH MIXTURES OF SOLUBLE AND LENTE OR SOLUBLE AND NPH SEMISYNTHETIC HUMAN INSULINS. 136
Four-year follow-up of glucose tolerance and beta-cell function in nondiabetic cystic fibrosis patients. 136
EFFETTO DEL DIABETE E DELLA MENOPAUSA SUL PROFILO LIPIDICO E LA DISTRIBUZIONE DELLE SOTTOPOPOLAZIONI HDL NELLE DONNE 135
Magnesium levels in plasma, erythrocyte, and platelet in hypertensive and normotensive patients with type II diabetes mellitus 135
Factors affecting diabetes mellitus onset in cystic fibrosis: Evidence from a 10-year follow-up study 135
The impact of clinical and psychological characteristics on alexithymia in type 1 diabetes 133
Genistein Supplementation and Cardiac Function in Postmenopausal Women with Metabolic Syndrome: Results from a Pilot Strain-Echo Study 132
AMD Annals: a model of continuous monitoring and improvement of the quality of diabetes care 130
Prevalenza dei fattori di rischio associati al diabete gestazionale e alla ridotta tolleranza glucidica in gravidanza 129
A preliminary study of the use of telemedicine system for monitoring diabetes during pregnancy 129
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity 129
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review 128
Prevalence of risk factors in the screening of carbohydrate intolerance in pregnancy 127
VALUTAZIONE LONGITUDINALE DI DONNE CON RIDOTTA TOLLERANZA GLUCIDICA IN GRAVIDANZA 125
Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study 125
Mild hyperhomocysteinemia and the common C677t polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes. 122
Predittività dell’OGTT sugli outcomes clinici ed ostetrici nella ridotta tolleranza glucidica in gravidanza 118
La disfunzione diastolica nel diabete gestazionale 117
Livelli plasmatici dei marcatori di flogosi nelle donne: influenza della menopausa e del diabete 117
Skin lesions in diabetes mellitus: prevalence and clinical correlations. 115
Totale 17.062
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.433
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.433
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.419 22 189 26 47 47 25 113 66 29 286 163 406
2022/20233.769 276 295 178 297 357 395 26 212 1.552 21 116 44
2023/2024983 79 157 65 123 74 158 34 56 0 40 6 191
2024/20254.241 58 59 96 258 192 161 80 874 1.072 256 432 703
2025/202611.931 598 816 817 732 904 2.641 1.477 1.486 1.537 473 235 215
2026/2027154 154 0 0 0 0 0 0 0 0 0 0 0
Totale 27.042